Why the study?
Are RAAS gene polymorphisms (ACE I/D, AGT M235T, AT1R A1166C) associated with hypertension in Hong Kong Chinese subjects?
Are RAAS gene polymorphisms (ACE I/D, AGT M235T, AT1R A1166C) associated with hypertension in Hong Kong Chinese subjects?
RAAS gene polymorphisms (ACE I/D, AGT M235T, AT1R A1166C) do not appear to be involved in the pathogenesis of hypertension in the Hong Kong Chinese population.
Does not support RAAS genotyping for hypertension risk in Chinese patients; leaves open ethnic-specific effects for further study.
In Chinese populations, hypertension is common and is a major risk factor for cerebrovascular and coronary heart disease. The renin-angiotensin-aldosterone system (RAAS) helps maintain blood pressure and salt homeostasis and appears important in the pathogenesis of hypertension and some forms of vascular disease. We investigated three RAAS gene polymorphisms, the angiotensin-converting enzyme (ACE) insertion/deletion, angiotensinogen (AGT) M235T and angiotensin II type 1 receptor A1166C polymorphisms in 232 hypertensive and 178 normotensive Chinese subjects. The hypertensives were generally more obese and dyslipidaemic. No significant differences in genotype or allele frequencies for any of the polymorphisms were identified between the groups, nor was there any interactive contribution to blood pressure by the ACE and AGT polymorphisms. However, there were large differences in genotype and allele frequencies between the healthy Chinese and published data for equivalent Caucasian populations. These findings suggest these polymorphisms are unlikely to be involved in the pathogenesis of hypertension in Chinese.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: